Amgen logo

Amgen

North America, California, United States, Thousand Oaks

Description

Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.

Investor Profile

Amgen has backed more than 18 startups, with 0 new investments in the last 12 months alone. The firm has led 7 rounds, about 39% of its total and boasts 8 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Corporate Round, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States, Germany, Israel.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series B (17%)
  • Corporate Round (17%)
  • Post Ipo Equity (11%)
  • Non Equity Assistance (11%)
  • Series Unknown (11%)
  • Series E (11%)
  • Series C (6%)
  • Grant (6%)
  • Post Ipo Debt (6%)
  • Series A (6%)

Country Focus

  • United States (78%)
  • Germany (11%)
  • Israel (6%)
  • United Kingdom (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Health Diagnostics
  • Enterprise Software
  • Medical Device
  • Analytics
  • Data Integration
  • Database
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Amgen frequently co-invest with?

Green D Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 2
Fenox Venture Capital
North America, San Jose, Costa Rica, California
Co-Investments: 1
Hewlett Packard Pathfinder
North America, California, United States, Palo Alto
Co-Investments: 1
Mubadala Capital Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Novartis
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
GE Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 2
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2

Which angels does Amgen often collaborate with?

LA
North America, California, United States, Palo Alto
Shared Deals: 1
Andrea Palmer
North America, Ontario, Canada, Toronto
Shared Deals: 1

What are some of recent deals done by Amgen?

Quantinuum

Broomfield, Colorado, United States

Quantinuum accelerates quantum computing and the development of applications across chemistry, cybersecurity, finance, and optimization.

Cyber SecurityQuantum ComputingSoftware Engineering
Corporate RoundJan 15, 2024
Amount Raised: $300,000,000
Generate Biomedicines

Somerville, Massachusetts, United States

Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.

BiotechnologyHealth CareMedicalProduct Research
Series CSep 15, 2023
Amount Raised: $273,000,000
Neumora Therapeutics

Watertown, Massachusetts, United States

Neumora Therapeutics operates as a clinical-stage biotechnology company.

BiotechnologyHealth CareMedical
Series BOct 11, 2022
Amount Raised: $112,000,000
Accure Health

Cambridge, Massachusetts, United States

Accure Health develops AI-powered, biomarker-guided solutions that enable precision therapies delivered to the right patients, right cells.

Health CareMedical
Non Equity AssistanceMar 1, 2022
Neumora Therapeutics

Watertown, Massachusetts, United States

Neumora Therapeutics operates as a clinical-stage biotechnology company.

BiotechnologyHealth CareMedical
Corporate RoundOct 7, 2021
Amount Raised: $100,000,000
Jasper Therapeutics

Redwood City, California, United States

Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquitySep 27, 2021
Amount Raised: $100,000,000
SomaLogic

Boulder, Colorado, United States

SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series ADec 23, 2020
Amount Raised: $81,000,000
Science 37

Culver City, California, United States

Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.

BiotechnologyClinical TrialsHealth CareHome Health Care
Series UnknownAug 20, 2020
Amount Raised: $40,000,000
Keck Graduate Institute

Claremont, California, United States

Keck Graduate Institute is a school.

EducationHigher Education
GrantDec 5, 2019
Amount Raised: $1,000,000
BeiGene

Cambridge, Massachusetts, United States

BeiGene is a global oncology company.

BiotechnologyHealth CareLife ScienceMedical
Post Ipo EquityOct 31, 2019
Amount Raised: $2,700,000,000